[ET Net News Agency, 17 September 2021] BEIGENE (06160) rose 10.54% to HK$256.
It hits an intra-day high of HK$256, hitting a historical high, and an intra-day low of
HK$227.2. The total shares traded was 487,998, with a value of HK$119.36m. The active
buy/sell ratio is 68:32, with net buying turnover of HK$41.75m. CITIGROUP GLOBAL accounts
for greatest net responsive buying turnover of HK$5.23m, with volume weighted average
price of HK$244.011. UBS SEC accounts for greatest net responsive selling turnover of
HK$12.54m, with volume weighted average price of HK$244.236. The stock has risen a
combined 25.24% over the past 6 consecutive trading days.
The Hang Seng Index now rose 39 points, or 0.16% to 24,707; the Hang Seng China
Enterprises Index now rose 53 points, or 0.6% to 8,858; the Hang Seng TECH Index now rose
121 points, or 1.95% to 6,354; with an overall turnover of HK$50.1b.
The SSE Composite Index now fell 1 points, or 0.03% to 3,605, with an overall turnover
of RMB264.01b.
The SZSE Component Index now fell 41 points, or 0.29% to 14,217, with an overall
turnover of RMB135.48b.
Basic Information
-------------------------------------------
Nominal 256.000 % Chg +10.54%
High 256.000 Low 227.200
Shares Tr 487,998 Turnover 119.36m
10-D SMA 219.580 %H.V 53.304
20-D SMA 199.435 VWAP 244.592
50-D SMA 190.432 RSI14 79.720
-------------------------------------------
Status: Hitting a historical high, active buy/sell ratio is 68:32, with net buying
turnover of HK$41.75m, rising a combined 25.24% over the past 6 consecutive
trading days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
BEIGENE (06160) 256.00 +10.54
GENSCRIPT BIO (01548) 32.75 +1.39
INNOVENT BIO (01801) 61.90 +1.31
JXR (01951) 12.20 +1.16
JW THERAP-B (02126) 17.46 +1.51
WUXI BIO (02269) 117.80 +1.20
TIGERMED (03347) 169.90 +2.84
CANSINOBIO-B (06185) 265.40 +1.30
AKESO-B (09926) 41.00 +0.24
KINTOR PHARMA-B (09939) 73.70 -1.47
-------------------------------------------------
(ed)